Glucagon-like peptide 1 receptor: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
The 3D crystal structure of the complex of GLP-1R (extra-cellular domain only) and GLP-1 shows the GLP-1 peptide as a kinked helix. The ampiphilic GLP-1 helix shows <scene name='84/841095/Cv/2'>hydrophilic</scene> and <scene name='84/841095/Cv/3'>hydrophobic</scene> interactions with GLP-1R on opposite faces<ref>PMID:19861722</ref>. <scene name='84/841095/Cv/5'>GLP-1R/GLP-1 salt bridges and H-bonds</scene>. | The 3D crystal structure of the complex of GLP-1R (extra-cellular domain only) and GLP-1 shows the GLP-1 peptide as a kinked helix. The ampiphilic GLP-1 helix shows <scene name='84/841095/Cv/2'>hydrophilic</scene> and <scene name='84/841095/Cv/3'>hydrophobic</scene> interactions with GLP-1R on opposite faces<ref>PMID:19861722</ref>. <scene name='84/841095/Cv/5'>GLP-1R/GLP-1 salt bridges and H-bonds</scene>. | ||
More recently, the structure of full-length GLP-1R was determined by cryo-EM, with or without bound agonist. | More recently, the structure of <scene name='10/1067195/Glp1_only/1'>full-length GLP-1R</scene> was determined by cryo-EM, with or without bound agonist. | ||
In regard to GLP-1R, GLP-1 is an agonist with very high binding affinity, in the nanomolar range, and changes to the specified residues can greatly impact binding affinity. As evidenced by the glucagon receptor, there are differences in the peptide-free and peptide-bound states with the most significant structural differences observed in the extracellular regions. The same applies to GLP-1 Receptor, with GLP-1 bound GLP-1R having an extended ECD as compared to the unbound GLP-1R. A large degree of conformational dynamics is critical for the binding of GLP-1. The N-terminus triggers a conformational change that results in G-protein coupling and activation of downstream signaling, while the C-terminus of the peptide initiates recognition of the ECD. There is a notable β-sheet motif when the GLP-1R has no bound peptide. This sheet is seen in the ECD which is important for the GLP-1 recognition and the conformational dynamic changes in the receptor when it is bound to a peptide versus when it is not. | In regard to GLP-1R, GLP-1 is an agonist with very high binding affinity, in the nanomolar range, and changes to the specified residues can greatly impact binding affinity. As evidenced by the glucagon receptor, there are differences in the peptide-free and peptide-bound states with the most significant structural differences observed in the extracellular regions. The same applies to GLP-1 Receptor, with GLP-1 bound GLP-1R having an extended ECD as compared to the unbound GLP-1R. A large degree of conformational dynamics is critical for the binding of GLP-1. The N-terminus triggers a conformational change that results in G-protein coupling and activation of downstream signaling, while the C-terminus of the peptide initiates recognition of the ECD. There is a notable β-sheet motif when the GLP-1R has no bound peptide. This sheet is seen in the ECD which is important for the GLP-1 recognition and the conformational dynamic changes in the receptor when it is bound to a peptide versus when it is not. | ||